NM23 in Ovarian Cancer. Correlation with clinicopathological and biochemical parameters.
Ferrandina
G
G
Department of Obstetrics and Gynecology, Catholic University, Rome, Italy.
Scambia
G
G
Marone
M
M
Benedetti Panici
P
P
Giannitelli
C
C
Pernisco
S
S
Coronetta
F
F
Mancuso
S
S
D000818:Animals; D014408:Biomarkers, Tumor / Q000032:analysis*; D066246:ErbB Receptors / Q000032:analysis; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D051379:Mice; D008875:Middle Aged; D020559:Monomeric GTP-Binding Proteins; D054778:NM23 Nucleoside Diphosphate Kinases; D009701:Nucleoside-Diphosphate Kinase; D010051:Ovarian Neoplasms / Q000201:enzymology* / Q000473:pathology / Q000648:ultrastructure; D011379:Prognosis; D014157:Transcription Factors / Q000032:analysis*
D014408:Biomarkers, Tumor; D054778:NM23 Nucleoside Diphosphate Kinases; D014157:Transcription Factors; D066246:ErbB Receptors; C517938:NME1 protein, human; C517939:Nme1 protein, mouse; D009701:Nucleoside-Diphosphate Kinase; D020559:Monomeric GTP-Binding Proteins